Hero Image
21 October 2022
Paris, France
Accélérer le développement de médicaments à l'aide de biomarqueurs d'imagerie biomédicale

October, 20: Virtual event


01:00 - 23:30    Virtual B2B matchmaking



October, 21: In person @ Cité Internationale Universitaire de Paris


08:30 - 09:00 Welcome & Coffee

09:00 - 09:15 Welcome remarks by PASREL-imagerie & 

Medicen

Vincent LEBON- PASREL-imagerie Director /Head of Hospital Service CEA-SHFJ / BioMaps Director
Etienne LONCHAMP - Innovation project manager - Diagnostic sector - Medicen

09:15 - 09:30 Opening

Stéphane THOLANDER - Coordinator of digital health commission France Biotech / Cibiltech CEO

09:30 - 10:15 Conference "Using PET imaging to enable 

neuroscience drug develoment"

Joel MERCIER - Director Medicinal and PET chemistry - UCB

10:15 - 11:00 Conference " PET microdosing with 

radiolabelled drugs "

Oliver LANGER- Associate Professor - Medical University of Vienna

11:00 - 11:30 Networking break


11:30 - 12:15 Round table - Isotope imaging for drug 

development: potential and challenges

Joel MERCIER - Director Medicinal and PET chemistry - UCB 
Oliver LANGER- Associate Professor - Medical University of Vienna 
Solène MARIE -  Associate Professor - Paris-Saclay University
Georges DA VIOLANTE - Head of Biotransformation & Biodistribution, DMPK, Translational Medicine - Servier
Mathieu CHARVERIAT
- Co-founder and CSO - Theranexus

12:15 - 13:30 Lunch


13:30 - 14:30 Successful academic/industrial collaborations 

for drug development using imaging

"From the disease to an imaging biomarker for  therapeutic monitoring" 
    Henri BENECH- General Manager & Cofounder - CERES-BRAIN Therapeutics
    Nicolas TOURNIER- Head of pharmacological Neuroimaging team - BioMaps/SHFJ

"Non-invasive multimodality imaging for immune cell tracking" 
    Erwan JOUANNOT- Head of global Bioimaging - Sanofi
    Sébastien MERIAUX- Head of multimodal / functional MRI - CEA / Neurospin

"Relevance of imaging readouts in the clinical translation of gene therapy for Parkinson’s disease" 
    Romina ARON BADIN - Deputy Director MIRCen

"Analysis of mRNA-Lipid nanoparticle distribution by in vivo imaging in two animal models" 
    Catherine CHAPON - Head of the Laboratory Imaging Infection and Immunity - IDMIT

14:30 - 15:00 Biotech Pitch

Thomas JOUDINAUD - CEO & cofounder : CERES-BRAIN Therapeutics 
Philippe JAIS - Chairman & CSO : Eukarys
Ludovic de ROCHEFORT - CEO : Ventio 
Vincent PERLBARG 
- CSO & President : Braintale
Tanguy BOISSENOT
 - CEO : Imescia
Morgane LE GUEVELLO
- Product Manager : Wainvam-e

15:00 - 18:00 On-site B2B Matchmaking


Registration
Closed since 19 October 2022
Location CITE INTERNATIONALE UNIVERSITAIRE DE PARIS
Organised by
Participants
France 118
China 1
Belgium 3
Algeria 1
India 2
United States 1
Netherlands 1
Italy 1
Austria 1
South Korea 2
Canada 1
Denmark 1
Ukraine 2
Switzerland 1
Total 136
Participants
Academia 50
Association/Agency 5
CRO/CMO/CDMO 4
Hospital 1
Investor/Finance 2
Manufacturer 6
Non-profit organisation 2
Pharmaceutical 18
Public authorities 2
Research & Developpment 20
Service provider 11
Therapeutics & Diagnostics 5
Other 9
Total 135